ChemicalBook > CAS DataBase List > MYCi975

MYCi975

Product Name
MYCi975
CAS No.
2289691-01-4
Chemical Name
MYCi975
Synonyms
MYCi975;NUCC-0200975;MYCi975 ,S8906;MYCi-975,MYCi975;MYCi975 (NUCC-0200975);MYCi975, 10 mM in DMSO;4’-Chloro-6-[(4-chlorobenzyl)oxy]-3-[1-methyl-3-(trifluoromethyl)-5-pyrazolyl]-3’-(trifluoromethyl)-[1,1’-biphenyl]-2-ol;4’-Chloro-6-[(4-chlorobenzyl)oxy]-3-[1-methyl-3-(trifluoromethyl)-5-pyrazolyl]-3’-(trifluoromethyl)-[1,1’-biphenyl]-2-ol;4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol;[1,1'-Biphenyl]-2-ol, 4'-chloro-6-[(4-chlorophenyl)methoxy]-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]-3'-(trifluoromethyl)-
CBNumber
CB95821225
Molecular Formula
C25H16Cl2F6N2O2
Formula Weight
561.3
MOL File
2289691-01-4.mol
More
Less

MYCi975 Property

Boiling point:
566.5±50.0 °C(Predicted)
Density 
1.45±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO:56.0(Max Conc. mg/mL);99.8(Max Conc. mM)
pka
7.99±0.50(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Axon Medchem
Product number
Axon3229
Product name
MYCi975-NUCC-0200975
Purity
99%
Packaging
2x5mg
Price
$176
Updated
2021/12/16
DC Chemicals
Product number
DC32580
Product name
MYCi975
Packaging
100mg
Price
$700
Updated
2021/12/16
More
Less

MYCi975 Chemical Properties,Usage,Production

Description

MYCi975 is an inhibitor of the protein-protein interaction between Myc and Myc-associated factor X (MAX).1 It binds to Myc (Kd = 2.75 µM) and increases GSK3β-mediated Myc phosphorylation in a cell-free assay. MYCi975 (5 and 10 µM) decreases the viability of MyC-CaP and LNCaP prostate cancer cells. It induces apoptosis in a panel of 11 breast cancer cell lines when used at a concentration of 10 µM.2 In vivo, MYCi975 (100 mg/kg) reduces tumor volume in a MyC-CaP mouse xenograft model.WARNING This product is not for human or veterinary use.

MYCi975 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MYCi975 Suppliers

Shanghai Synteam Biochem CO.,ltd
Tel
+86-021-58380978 13482386415
Fax
021-58380978
Email
info@systeambc.com
Country
China
ProdList
896
Advantage
50
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4757
Advantage
55
Suzhou Unite pharmTech Co., Ltd ,
Tel
792-3901125 13222993784
Fax
0512-62575043
Email
sales@unite-pharm.com
Country
China
ProdList
311
Advantage
56
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2986
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9119
Advantage
58
Shanghai SuperLan Chemcial Technique Centre
Tel
0-2022843681 15618226720
Fax
+86-21-51601218
Email
chaolaichem@foxmail.com
Country
China
ProdList
12476
Advantage
58
Chuzhou KeMail Chemical Technology Co., Ltd
Tel
0550-5196001 15000891977
Fax
0550-5196001
Email
wj520wjxby@126.com
Country
China
ProdList
1944
Advantage
55

2289691-01-4, MYCi975Related Search:


  • MYCi975
  • NUCC-0200975
  • [1,1'-Biphenyl]-2-ol, 4'-chloro-6-[(4-chlorophenyl)methoxy]-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]-3'-(trifluoromethyl)-
  • MYCi975 (NUCC-0200975)
  • MYCi-975,MYCi975
  • 4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol
  • 4’-Chloro-6-[(4-chlorobenzyl)oxy]-3-[1-methyl-3-(trifluoromethyl)-5-pyrazolyl]-3’-(trifluoromethyl)-[1,1’-biphenyl]-2-ol
  • MYCi975, 10 mM in DMSO
  • 4’-Chloro-6-[(4-chlorobenzyl)oxy]-3-[1-methyl-3-(trifluoromethyl)-5-pyrazolyl]-3’-(trifluoromethyl)-[1,1’-biphenyl]-2-ol
  • MYCi975 ,S8906
  • 2289691-01-4
  • C25H16Cl2F6N2O2